Abstract:Introduction: Fibroblast growth factor receptor 3 (FGFR3) is a tyrosine kinase membrane-spanning protein whose function is to regulate chondrocyte proliferation, differentiation and matrix production during cartilage development. Several mutations in FGFR3 have now been documented to link to human diseases. A number of these mutations result in constitutive activation of the FGFR3, leading to proliferation and premature differentiation of chondrocytes. Depending on the mutation and the resultant level of FGFR3 activation, mild to severe skeletal dysplasias such as achondroplasia (ACH), hypochondroplasia (HCH), thanatophoric dysplasia type I (TDI) and type II (TDII), and severe achondroplasia with developmental delay and acanthosis nigrans (SADDAN) may result. It has been postulated that the signalling pathways downstream of FGFR3 may be responsible for activating transcription factors, leading to up-regulation of cell cycle inhibitors and causing abnormal suppression of chondrocyte cell proliferation. However, the precise signalling pathways involved in FGFR3 mutation have as yet to be elucidated. The aim of this study was to investigate and compare the differences in the downstream signalling pathways between FGFR3 mutants. Methods and Results: Wild type FGFR3 has been cloned into expression vector pcDNA3 and the construct has been used to generate four different FGFR3 mutants using site-directed mutagenesis. The mutations which have been introduced and the types of dysplasia they correspond to were as follows: K380R (ACH), N540K (HCH) and K650E (TDII). A kinase dead form of the receptor, K504R has also been generated. Wild type and each of the four mutant FGFR3 proteins in pcDNA3 vector have been successfully transfected into 293T cells using the calcium phosphate method. Immunoprecipitation and Western Blot analysis of cell lysates revealed expression of wild type protein in three isoforms of size 135kDa (mature), 120kDa (intermediate) and 98kDa (immature). The mutant proteins all followed a similar pattern of expression with the exception of the TDII mutant that did not express the mature form of the FGFR3. Changes in MAPK, PLCa and STAT 1 signalling pathways in response to FGFs-1, 2, 9 and 18 in the 293-cells of wild type and mutant forms of FGFR3 are now under investigation, in an attempt to define which pathways are mostly responsible for the resultant abnormal phenotypes. Discussion: Genomics studies have demonstrated that FGFR3 expression is significantly upregulated during the osteoblastic differentiation of mesenchymal stem cells (MSCs) under BMP-2 stimulation in vitro. Subsequent functional studies have demonstrated that a selective ligand for FGFR3, FGF9, is able to induce tyrosine kinase signalling, and the osteoblastic differentiation of MSCs in vitro. Further understanding the signalling mechanisms of FGFR3 activation in normal and mutant forms may lead to discover potential anabolic agents that are based on FGFR3-FGFs pathways.

FGFR3 EXPRESSION PATTERN DURING THE DEVELOPMENT OF MOUSE EMBRYONAL LIMB BUD DETECTED BY MICROARRAY ANALYSIS

Expression of MPCR1 during murine embryonic development

Dynamic Expression of FGF3 Gene during Zebrafish Embryonic Development

FGFR1 Function at the Earliest Stages of Mouse Limb Development Plays an Indispensable Role in Subsequent Autopod Morphogenesis.

Conditional Inactivation of Fgfr1 in Mouse Defines Its Role in Limb Bud Establishment, Outgrowth and Digit Patterning

Expressive trend of growth differentiation factor 5 during limb skeletal development of mice

Expression of GDF-5 During the Development of Limb Skeleton System of Mice and the Effect of GDF-5 on Limb Bud Cell

Generation of Fgfr3 Conditional Knockout Mice

Expression Profile of Fibroblast Growth Factor in MAPK Signaling Pathway During Chondrogenesis in Mice

Fibroblast Growth Factor Receptor 2 (Fgfr2)-Mediated Reciprocal Regulation Loop Between FGF8 and FGF10 is Essential for Limb Induction

FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3): COMPARISON OF THE SIGNALLING PATHWAYS ACTIVATED BY THE WILD TYPE AND ITS MUTANT RECEPTORS

Expression and Methylation of FGF2, TGF-β and Their Downstream Mediators During Different Developmental Stages of Leg Muscles in Chicken.

Expression of AI429618 Gene During Mouse Embryonic Development

Expression Trend of GDF-5 During Limb Skeletal Development of Rat

[Expression of Junctophilin 1 during cardiogenesis of mouse embryonic stem cells and rat embryos].

A Neonatal Lethal Mutation in FGFR3 Uncouples Proliferation and Differentiation of Growth Plate Chondrocytes in Embryos.

FGFR3 Induces Degradation of BMP Type I Receptor to Regulate Skeletal Development.

FGF Ligand Family mRNA Expression Profile for Mouse Preimplantation Embryos, Early Gestation Human Placenta, and Mouse Trophoblast Stem Cells

Expression of FGF4 in Bovine Embryos at Early Developmental Stage

Murine Fgfr-1 Is Required For Early Postimplantation Growth And Axial Organization

Expression and Regulation of Ypel3 Gene During Mouse Embryo Development